Transport of nitric oxide synthase inhibitors through cationic amino acid carriers in human erythrocytes

Biochem Pharmacol. 1995 Dec 22;50(12):1963-8. doi: 10.1016/0006-2952(95)02090-x.

Abstract

The interaction of arginine analogues, which are known to inhibit nitric oxide synthase, with two cationic amino acid transporters of human erythrocytes (systems y+ and y+L) was studied. Arginine and relevant analogues [NG-monomethyl-L-arginine (L-NMMA); NG-monomethyl-D-arginine (D-NMMA) and NG-nitro-L-arginine (L-NOARG)] were found to inhibit labeled lysine influx into intact erythrocytes. As expected, the pattern of inhibition reflected the contribution of the two distinct transport systems. All analogues showed a higher affinity for system y+L than for system y+. The half-saturation (inhibition) constants estimated for systems y+ and y+L (+/- SEM) were (microM): L-arginine, 55.7 +/- 5.4 and 2.4 +/- 0.1; L-NMMA, 151 +/- 13 and 7.5 +/- 0.5; D-NMMA, 2660 +/- 404 and 269 +/- 25; L-NOARG, 9414 +/- 169 and 594 +/- 35. The transport properties of the analogues were investigated using an assay based on the trans-stimulation of lysine efflux. The addition of saturating concentrations of unlabeled analogues to the external medium stimulated efflux of labeled lysine through systems y+L and y+, showing that the analogues can enter the cell through these pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arginine / analogs & derivatives*
  • Arginine / pharmacology
  • Biological Transport / drug effects
  • Cations
  • Erythrocytes / metabolism*
  • Ethylmaleimide / pharmacology
  • Humans
  • Kinetics
  • Lysine / metabolism
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Nitroarginine
  • omega-N-Methylarginine

Substances

  • Cations
  • Nitroarginine
  • omega-N-Methylarginine
  • Arginine
  • Nitric Oxide Synthase
  • Lysine
  • Ethylmaleimide